Suppr超能文献

ATG16L、NOD2 和 IL23R 在克罗恩病发病机制中的作用。

Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis.

机构信息

Department of Molecular Biology and Microbiology, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32816, USA.

出版信息

World J Gastroenterol. 2012 Feb 7;18(5):412-24. doi: 10.3748/wjg.v18.i5.412.

Abstract

Inflammatory bowel disease is a group of diseases that includes Crohn's disease (CD) and ulcerative colitis. CD is characterized as a chronic inflammatory disease of the gastrointestinal tract, ranging from the mouth to the anus. Although there are gross pathological and histological similarities between CD and Johne's disease of cattle, the cause of CD remains controversial. It is vital to understand fully the cause of this disease because it affects approximately 500,000 people in North America and Europe. It ranges from 27 to 48 cases per 100,000 people. There are many theories on the cause of CD ranging from possible association with environmental factors including microorganisms to imbalance in the intestinal normal flora of the patients. Regardless of the environmental trigger, there is strong evidence that a genetic disposition is a major key in acquiring CD. Many studies have proven the link between mutations in the ATG16L, NOD2/CARD15, IBD5, CTLA4, TNFSF15 and IL23R genes, and CD. The purpose of this review is to examine all genetic aspects and theories of CD, including up to date multiple population studies performed worldwide.

摘要

炎症性肠病是一组疾病,包括克罗恩病(CD)和溃疡性结肠炎。CD 是一种胃肠道的慢性炎症性疾病,范围从口腔到肛门。虽然 CD 和牛的 Johne 病在大体病理和组织学上有相似之处,但 CD 的病因仍存在争议。充分了解这种疾病的病因至关重要,因为它影响了北美和欧洲约 50 万人。其发病率为每 10 万人 27 至 48 例。关于 CD 的病因有许多理论,从可能与环境因素(包括微生物)有关到患者肠道正常菌群失衡不等。无论环境触发因素如何,都有强有力的证据表明遗传倾向是获得 CD 的主要关键。许多研究已经证明了 ATG16L、NOD2/CARD15、IBD5、CTLA4、TNFSF15 和 IL23R 基因突变与 CD 之间的联系。本综述的目的是检查 CD 的所有遗传方面和理论,包括全球范围内进行的最新多人群研究。

相似文献

1
Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis.
World J Gastroenterol. 2012 Feb 7;18(5):412-24. doi: 10.3748/wjg.v18.i5.412.
2
NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.
World J Gastroenterol. 2010 Apr 14;16(14):1753-8. doi: 10.3748/wjg.v16.i14.1753.
5
Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Am J Gastroenterol. 2009 Jul;104(7):1723-33. doi: 10.1038/ajg.2009.184. Epub 2009 May 19.
6
IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.
Am J Gastroenterol. 2007 Dec;102(12):2754-61. doi: 10.1111/j.1572-0241.2007.01525.x. Epub 2007 Sep 25.
7
Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients.
World J Gastroenterol. 2010 Jan 14;16(2):176-83. doi: 10.3748/wjg.v16.i2.176.
9
NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
World J Gastroenterol. 2010 Jan 21;16(3):359-64. doi: 10.3748/wjg.v16.i3.359.
10
Classification of genetic profiles of Crohn's disease: a focus on the ATG16L1 gene.
Expert Rev Mol Diagn. 2008 Mar;8(2):199-207. doi: 10.1586/14737159.8.2.199.

引用本文的文献

1
Role of ETS2 gene in inflammatory bowel disease: A narrative review.
Medicine (Baltimore). 2025 Sep 5;104(36):e44234. doi: 10.1097/MD.0000000000044234.
3
Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date.
Int J Mol Sci. 2025 Jan 6;26(1):413. doi: 10.3390/ijms26010413.
4
Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons.
Int J Mol Sci. 2024 Jun 7;25(12):6326. doi: 10.3390/ijms25126326.
5
NOD2 and Crohn's Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired.
Inflamm Bowel Dis. 2025 Feb 6;31(2):552-562. doi: 10.1093/ibd/izae075.
6
Transcriptome-wide association studies associated with Crohn's disease: challenges and perspectives.
Cell Biosci. 2024 Feb 25;14(1):29. doi: 10.1186/s13578-024-01204-w.
7
Molecular Foundations of Inflammatory Diseases: Insights into Inflammation and Inflammasomes.
Curr Issues Mol Biol. 2024 Jan 3;46(1):469-484. doi: 10.3390/cimb46010030.
8
Ophthalmological Manifestations in Inflammatory Bowel Diseases: Keep an Eye on It.
Cells. 2024 Jan 12;13(2):142. doi: 10.3390/cells13020142.
9
A Review of Ophthalmic Complications in Inflammatory Bowel Diseases.
J Clin Med. 2022 Dec 15;11(24):7457. doi: 10.3390/jcm11247457.
10
Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn's Disease.
J Clin Med. 2022 Nov 28;11(23):7020. doi: 10.3390/jcm11237020.

本文引用的文献

2
NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.
World J Gastroenterol. 2010 Apr 14;16(14):1753-8. doi: 10.3748/wjg.v16.i14.1753.
3
NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
World J Gastroenterol. 2010 Jan 21;16(3):359-64. doi: 10.3748/wjg.v16.i3.359.
4
Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients.
World J Gastroenterol. 2010 Jan 14;16(2):176-83. doi: 10.3748/wjg.v16.i2.176.
5
Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Am J Gastroenterol. 2009 Jul;104(7):1723-33. doi: 10.1038/ajg.2009.184. Epub 2009 May 19.
6
IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein.
PLoS One. 2009;4(3):e4719. doi: 10.1371/journal.pone.0004719. Epub 2009 Mar 5.
8
The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy.
Mol Biol Cell. 2008 May;19(5):2092-100. doi: 10.1091/mbc.e07-12-1257. Epub 2008 Mar 5.
9
Inflammatory bowel disease: genetic and epidemiologic considerations.
World J Gastroenterol. 2008 Jan 21;14(3):338-47. doi: 10.3748/wjg.14.338.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验